{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:34:26Z","timestamp":1759541666321,"version":"3.41.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ejphar.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T09:10:30Z","timestamp":1428743430000},"page":"31-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of nebivolol treatment during pregnancy on the genital circulation, fetal growth and postnatal development in the Wistar rat"],"prefix":"10.1016","volume":"758","author":[{"given":"Kassem","family":"Altoama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Yassine Mallem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Thorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Betti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1124-7979","authenticated-orcid":false,"given":"Jean-Claude","family":"Desfontis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00005344-200009000-00006","article-title":"Nebivolol induces NO-mediated relaxations of rat small mesenteric but not of large elastic arteries","volume":"36","author":"Altwegg","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2015.04.001_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/00005344-200006000-00003","article-title":"Nebivolol inhibits human aortic smooth muscle cell growth: effects of cell cycle regulatory proteins","volume":"35","author":"Andr\u00e9","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5 suppl 1","key":"10.1016\/j.ejphar.2015.04.001_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005344-200036051-00117","article-title":"Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells","volume":"36","author":"Brehm","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.04.001_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0008-6363(00)00253-4","article-title":"Effects of nebivolol on proliferation and apoptosis of human coronary artery smooth muscle and endothelial cells","volume":"49","author":"Brehm","year":"2001","journal-title":"J. Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.ejphar.2015.04.001_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.CIR.102.6.677","article-title":"Nebivolol: a third-generation beta-blocker that augments vascular nitric oxide release: endothelial beta (2)-adrenergic receptor-mediated nitric oxide production","volume":"102","author":"Broeders","year":"2000","journal-title":"J. Circ."},{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)10549-1","article-title":"Nebivolol vasodilates human forearm vasculature: evidence for an arginine\/NO-dependent mechanism","volume":"274","author":"Cockcroft","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2015.04.001_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00004872-200203000-00017","article-title":"Nitric-oxide-mediated relaxations in salt-induced hypertension: effect of chronic beta1-selective receptor blockade","volume":"20","author":"Cosentino","year":"2002","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib8","first-page":"285","article-title":"Comparison of three vascular endothelial markers in the evaluation of microvessel density in breast cancer","volume":"30","author":"Da Silva","year":"2009","journal-title":"Eur. J. Gynaecol. Oncol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.04.001_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00005344-200308000-00012","article-title":"Involvement of the beta 3 adrenoreceptor in nebivolol-induced vasorelaxation in the rat aorta","volume":"42","author":"De Groot","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2007.12.010","article-title":"Prominent cardioprotective effects of third generation beta blocker nebivolol against anthracycline-induced cardiotoxicity using the model of isolated perfused rat heart","volume":"44","author":"De Nigris","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejphar.2015.04.001_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.niox.2008.03.004","article-title":"Therapeutic dose of nebivolol, a nitric oxide-releasing b-blocker, reduces atherosclerosis in cholesterol-fed rabbits","volume":"19","author":"De Nigris","year":"2008","journal-title":"J. Nitric Oxide"},{"key":"10.1016\/j.ejphar.2015.04.001_bib12","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2460\/ajvr.1972.33.12.2561","article-title":"Vascular anatomy of the uterus and ovaries and the unilateral luteolytic effect of the uterus: Guina pigs, rats, hamsters, and rabbits","volume":"33","author":"Del campo","year":"1972","journal-title":"Am. J. Vet. Res."},{"issue":"1-3","key":"10.1016\/j.ejphar.2015.04.001_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.11.043","article-title":"The cellular mechanisms involved in the vasodilator effect of nebivolol on the renal artery","volume":"508","author":"Georgescu","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2015.04.001_bib14","doi-asserted-by":"crossref","first-page":"H514","DOI":"10.1152\/ajpheart.00626.2006","article-title":"Blockade of both alpha1A- and alpha1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery","volume":"293","author":"Hosoda","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2015.04.001_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1089-8603(02)00112-X","article-title":"Nebivolol: a selective beta (1)-adrenergic receptor antagonist that relaxes vascular smooth muscle by nitric oxide- and cyclic GMP-dependent mechanisms","volume":"7","author":"Ignarro","year":"2002","journal-title":"J. Nitric Oxide"},{"issue":"6","key":"10.1016\/j.ejphar.2015.04.001_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.HYP.28.6.1064","article-title":"Methods of experimental hypertension in mice","volume":"28","author":"Johns","year":"1996","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.ejphar.2015.04.001_bib17","first-page":"283","article-title":"Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients","volume":"8","author":"Lacourci\u00e8re","year":"1994","journal-title":"J. Hum. Hypertens."},{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ancard.2010.05.004","article-title":"Advantages of vasodilating beta-blockers in congestive heart failure","volume":"59","author":"Logeart","year":"2010","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"key":"10.1016\/j.ejphar.2015.04.001_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0301-2115(99)00113-X","article-title":"Risks and benefits of b-receptor blockers for pregnancy hypertension: overview of the randomized trials","volume":"88","author":"Magee","year":"2000","journal-title":"Eur J. Obstet. Gynecol. Reprod. Biol."},{"issue":"7194","key":"10.1016\/j.ejphar.2015.04.001_bib20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","article-title":"Fortnightly review: management of hypertension in pregnancy","volume":"318","author":"Magee","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2015.04.001_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"ESH\/ESC guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.ejphar.2015.04.001_bib22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2165\/00003495-199957040-00011","article-title":"Nebivolol in the management of essential hypertension","volume":"57","author":"McNeely","year":"1999","journal-title":"Drugs"},{"issue":"16","key":"10.1016\/j.ejphar.2015.04.001_bib23","first-page":"735","article-title":"The somewhat-different \u03b2-adrenergic receptor blocker","volume":"54","author":"M\u00fcnzel","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.04.001_bib24","first-page":"101","article-title":"Adaptation of the uterine arcade in rats to pregnancy","volume":"12","author":"Nienartowicz","year":"1989","journal-title":"J. Dev. Physiol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.04.001_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0022-3565(24)35341-8","article-title":"Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol","volume":"292","author":"Parenti","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.ejphar.2015.04.001_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00045391-199905000-00004","article-title":"Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patiens with mild-moderate hypertension","volume":"6","author":"Pesant","year":"1999","journal-title":"Am. J. Ther."},{"year":"2000","author":"Pinheiro","series-title":"Mixed-Effects Models in S and Splus","key":"10.1016\/j.ejphar.2015.04.001_bib27"},{"issue":"8","key":"10.1016\/j.ejphar.2015.04.001_bib28","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/00004872-200108000-00011","article-title":"Effects of nebivolol and atenolol on insulin sensitivity and hemodynamics in hypertensive patients","volume":"19","author":"Poirier","year":"2001","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.ejphar.2015.04.001_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.jhh.1001257","article-title":"Integrated effects of vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension","volume":"15","author":"Predel","year":"2001","journal-title":"J. Hum. Hypertens."},{"year":"2013","author":"Core Team","series-title":"R: A Language and Environment for Statistical Computing","key":"10.1016\/j.ejphar.2015.04.001_bib30"},{"issue":"Suppl 3","key":"10.1016\/j.ejphar.2015.04.001_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005344-200112003-00003","article-title":"Nebivolol: endothelium-mediated vasodilating effect","volume":"38","author":"Ritter","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.04.001_bib32","first-page":"788","article-title":"Pharma-clinics medication of the month, Nebivolol (Nobiten)","volume":"56","author":"Scheen","year":"2001","journal-title":"Rev. Med. Liege."},{"issue":"5","key":"10.1016\/j.ejphar.2015.04.001_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2010.09.037","article-title":"Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional \u03b21-blockade","volume":"57","author":"Sorrentino","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2015.04.001_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ancard.2010.03.001","article-title":"Endothelial dysfunction: role of vasodilating betablockers in hypertension and chronic heart failure","volume":"59","author":"Thuillez","year":"2010","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"issue":"5","key":"10.1016\/j.ejphar.2015.04.001_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/hc3001.094207","article-title":"Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double blind crossover study","volume":"104","author":"Tzemos","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejphar.2015.04.001_bib36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00005344-199306000-00002","article-title":"Nebivolol in hypertension: a double-blind placebo controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life","volume":"21","author":"Van Bortel","year":"1993","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"9198","key":"10.1016\/j.ejphar.2015.04.001_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(98)08049-0","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis","volume":"355","author":"Von Dadelszen","year":"2000","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.ejphar.2015.04.001_bib38","first-page":"631","article-title":"Nebivolol: a beta blocker with vasodilator properties","volume":"89","author":"Waeber","year":"2000","journal-title":"Praxis"},{"issue":"4","key":"10.1016\/j.ejphar.2015.04.001_bib39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/1074248409350138","article-title":"Neither K+ channels nor PI3K\/Akt mediates the vasodilative effect of nebivolol on different types of rat arteries","volume":"14","author":"Wang","year":"2009","journal-title":"J. Cardiovasc. Pharmacol. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915003180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T10:47:47Z","timestamp":1747910867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915003180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":39,"alternative-id":["S0014299915003180"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.001","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of nebivolol treatment during pregnancy on the genital circulation, fetal growth and postnatal development in the Wistar rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}